• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Am Heart J. A care pathway for the cardiovascular complications of COVID-19: Insights from an institutional response

tetano

Editor, Senior Moderator
Am Heart J. 2020 May 3;225:3-9. doi: 10.1016/j.ahj.2020.04.024. [Epub ahead of print]
A care pathway for the cardiovascular complications of COVID-19: Insights from an institutional response.


Loungani RS[SUP]1[/SUP], Rehorn MR[SUP]2[/SUP], Newby LK[SUP]2[/SUP], Katz JN[SUP]2[/SUP], Klem I[SUP]2[/SUP], Mentz RJ[SUP]2[/SUP], Jones WS[SUP]2[/SUP], Vemulapalli S[SUP]2[/SUP], Kelsey AM[SUP]2[/SUP], Blazing MA[SUP]2[/SUP], Piccini JP[SUP]2[/SUP], Patel MR[SUP]2[/SUP].

Author information




Abstract

The infection caused by severe acute respiratory syndrome coronavirus-2, or COVID-19, can result in myocardial injury, heart failure, and arrhythmias. In addition to the viral infection itself, investigational therapies for the infection can interact with the cardiovascular system. As cardiologists and cardiovascular service lines will be heavily involved in the care of patients with COVID-19, our division organized an approach to manage these complications, attempting to balance resource utilization and risk to personnel with optimal cardiovascular care. The model presented can provide a framework for other institutions to organize their own approaches and can be adapted to local constraints, resource availability, and emerging knowledge.
Copyright ? 2020 Elsevier Inc. All rights reserved.



PMID:32417526DOI:10.1016/j.ahj.2020.04.024
 
Back
Top Bottom